Chronic Hepatitis C
Links shared publicly online about this topic
Viusid - A Nutritional Supplement For Treating Chronic Hepatitis C
medicalnewstoday.com — “The pathogenesis of chronic hepatitis C (CHC) is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis.” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2010 at 12:10 pm By:
Viusid - A Nutritional Supplement For Treating Chronic Hepatitis C http://mnt.to/3F2X #liver #hepatitis
Treatment For Chronic Hepatitis C: A Phase II Study
medicalnewstoday.com — “The current standard treatment for chronic hepatitis C with pegylated-interferon (PEG-IFN) and ribavirin is effective in approximately 50%-60% of patients, so that a substantial proportion of pati” View full resource at medicalnewstoday.com
Most Recently Shared on January 18, 2010 at 2:13 pm By:
MNT Clinical Trials Health News
Treatment For Chronic Hepatitis C: A Phase II Study http://mnt.to/3wrN
Victrelis Approved for Chronic Hepatitis C --Doctors Lounge
doctorslounge.com — “Victrelis Approved for Chronic Hepatitis C --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 16, 2011 at 9:10 pm By:
Drugs and Devices OW OW Health
Victrelis Approved for Chronic Hepatitis C: In combination with two other drugs http://bit.ly/msx4QE
A nutritional supplement for treating chronic hepatitis C: Viusid
physorg.com — “A research team from Cuba investigated the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C. Their results showed that treatment with Viusid leads to a notable improvement of oxidative stress and immunological parameters in such ...” View full resource at physorg.com
Most Recently Shared on June 17, 2010 at 2:20 pm By:
PhysOrg Health News Health News
A nutritional supplement for treating chronic hepatitis C: Viusid http://tw.physorg.com/195986126
Victrelis Approved for Chronic Hepatitis C - ONA
oncologynurseadvisor.com — “Merck announced that the FDA has approved Victrelis (boceprevir), a hepatitis C virus protease inhibitor, for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients 18 years of age with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 16, 2011 at 3:14 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Victrelis Approved for Chronic Hepatitis C http://goo.gl/fb/Sjo2D
Are Autoantibodies Relevant in Chronic Hepatitis C Infection? | Gastroenterology
touchgastroenterology.com — “Hepatitis C, autoantibodies, antinuclear antibody, antismooth muscle antibody, antiviral therapy” View full resource at touchgastroenterology.com
Most Recently Shared on July 8, 2011 at 11:52 am By:
touchGASTRO Gastroenterology and Medical Journal
Are Autoantibodies Relevant in Chronic Hepatitis C Infection? http://bit.ly/r2BG4g
Victrelis Approved for Chronic Hepatitis C - MPR
empr.com — “Merck announced that the FDA has approved Victrelis (boceprevir), a hepatitis C virus protease inhibitor, for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients 18 years of age with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.” View full resource at empr.com
Most Recently Shared on May 16, 2011 at 3:31 pm By:
MPR News: Victrelis Approved for Chronic Hepatitis C: Merck announced that the FDA has approved Victrelis (bocep... http://bit.ly/j1wL3a
Boceprevir and telaprevir for the treatment of chronic hepatitis C gen
dovepress.com — “Peer reviewed article authored by (Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ). Read article or submit your manuscript for publishing.” View full resource at dovepress.com
Most Recently Shared on March 27, 2012 at 4:32 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Boceprevir and telaprevir hepatitis C genotype 1:an indirect comparison meta-analysishttp://www.dovepress.com/articles.php?article_id=9446
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)
theannals.com — “Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)” View full resource at theannals.com
Most Recently Shared on August 10, 2011 at 4:57 am By:
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September): OBJECTIVE:To review the p... http://bit.ly/rrZDSP
Pharmasset Announces The Expansion Of The ELECTRON Trial In Chronic Hepatitis C
medicalnewstoday.com — “Pharmasset, Inc. (Nasdaq: VRUS) announced the addition of three treatment cohorts to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatiti” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 8:05 am By:
Pharmasset Announces The Expansion Of The ELECTRON Trial In Chronic Hepatitis C http://mnt.to/3WXr #liver #hepatitis
Boceprevir Approved By FDA To Treat Chronic Hepatitis C | ThirdAge
thirdage.com — “Boceprevir (Victrelis), one of a new class of drugs, was approved by the FDA to treat chronic hepatitis C infection.” View full resource at thirdage.com
Most Recently Shared on May 17, 2011 at 7:43 pm By:
Boceprevir Approved By FDA To Treat Chronic Hepatitis C http://bit.ly/k7qTte
Taribavirin offers a safe, effective alternative for chronic hepatitis C
physorg.com — “Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology.” View full resource at physorg.com
Most Recently Shared on September 22, 2010 at 1:59 pm By:
PhysOrg Health News Health News
Taribavirin offers a safe, effective alternative for chronic hepatitis C http://tw.physorg.com/204368367
Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective
news-medical.net — “The current standard treatment for chronic hepatitis C with pegylated-interferon (PEG-IFN) and ribavirin is effective in approximately 50%-60% of patients, so that a substantial proportion of patients remain unresponsive.” View full resource at news-medical.net
Most Recently Shared on January 18, 2010 at 5:19 am By:
Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective: The current standard t... http://bit.ly/5ana3F
Merck receives FDA approval for Victrelis to treat chronic hepatitis C
news-medical.net — “The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment.” View full resource at news-medical.net
Most Recently Shared on May 16, 2011 at 4:38 am By:
Merck receives FDA approval for Victrelis to treat chronic hepatitis C: The U.S. Food and Drug Administration to... http://bit.ly/mtrFts
Phase 3 study of Albuferon for chronic hepatitis C - MPR
empr.com — “Human Genome Sciences reported that the final results of two pivotal Phase 3 trials demonstrated that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to Pegasys (peginterferon alfa-2a) in the treatment of patients with chronic hepatitis C (HCV).” View full resource at empr.com
Most Recently Shared on April 28, 2009 at 1:59 am By:
MPR News: Phase 3 study of Albuferon for chronic hepatitis C: Human Genome Sciences reported that the f.. http://tinyurl.com/clg6so
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Liver Disease
The latest liver disease / hepatitis news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
